About Ipca Laboratories
Ipca Laboratories is a company based in Mumbai (India) founded in 1949. It operates as a Reseller / Distribution. The company has 23,240 employees as of March 31, 2024. Ipca Laboratories has completed 3 acquisitions, including Bayshore Pharmaceuticals, Noble Explochem and Ramdev Chemicals. Ipca Laboratories offers products and services including APIs, Formulations, and Generics.
- Headquarter Mumbai, India
- Employees 23240 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ipca Laboratories Limited
-
Annual Revenue
$1.04 B (USD)16.23as on Mar 31, 2025
-
Net Profit
$86.38 M (USD)34.77as on Mar 31, 2025
-
EBITDA
$201.79 M (USD)49.21as on Mar 31, 2025
-
Latest Funding Round
$40 M (USD), Post-IPO
Mar 25, 2013
- Investors
-
Employee Count
23240
as on Mar 31, 2024
-
Investments & Acquisitions
Bayshore Pharmaceuticals
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Ipca Laboratories
Ipca Laboratories is a publicly listed company on the NSE with ticker symbol IPCALAB in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Ipca Laboratories
Ipca Laboratories offers a comprehensive portfolio of products and services, including APIs, Formulations, and Generics.
Active pharmaceutical ingredients are produced for global markets.
Formulated drugs are developed for various health conditions.
Generic medicines are offered at competitive market prices.
People of Ipca Laboratories
Unlock access to complete
Unlock access to complete
Funding Insights of Ipca Laboratories
Investors in Ipca Laboratories
Ipca Laboratories has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include ChrysCapital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment firm focusing on private equity in sectors like financial services and healthcare.
|
Locked | Locked | Locked |
Investor details for Ipca Laboratories
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ipca Laboratories
Ipca Laboratories has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Bayshore Pharmaceuticals, Noble Explochem and Ramdev Chemicals.
Investment portfolio details for Ipca Laboratories
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Manufacturer of pharmaceutical products
|
Locked | Locked | 2011 | Locked | |
|
APIs, intermediates, specialty chemicals, and custom synthesis molecules are manufactured.
|
Locked | Locked | 1999 | Locked | |
|
Industrial chemicals and explosives are manufactured and distributed.
|
Locked | Locked | 0 | Locked |
Complete acquisition details for Ipca Laboratories
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Ipca Laboratories
Detailed financials for Ipca Laboratories
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ipca Laboratories Comparisons
Peer comparison for Ipca Laboratories
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ipca Laboratories
Detailed competitors of Ipca Laboratories
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ipca Laboratories
Complete news archive for Ipca Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ipca Laboratories
Ipca Laboratories was founded in 1949 and raised its 1st funding round 64 years after it was founded.
Ipca Laboratories is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Pranay Godha is the current CEO of Ipca Laboratories.
As of Mar 31, 2024, the latest employee count at Ipca Laboratories is 23,240.
Annual revenue of Ipca Laboratories is $1.04B as on Mar 31, 2025.
Ipca Laboratories is involved in the production and distribution of active pharmaceutical ingredients (APIs), formulations, and generic medicines. The company operates within the healthcare sector, focusing on providing affordable healthcare solutions globally. Emphasis is placed on backward integration to ensure a reliable supply chain and cost competitiveness. Expansion in the generic drug space is pursued to enhance market reach. Corporate social responsibility initiatives are undertaken to support patient health, environmental sustainability, and community development.
Ipca Laboratories offers APIs, Formulations, and Generics.
Yes, Ipca Laboratories is publicly traded on NSE under the ticker symbol IPCALAB.
Ipca Laboratories has made 3 acquisitions, including Bayshore Pharmaceuticals, Noble Explochem, and Ramdev Chemicals.
Ipca Laboratories has 1 investor. Key investors include ChrysCapital.
The ticker symbol of Ipca Laboratories is IPCALAB on NSE.